Background: Exposure to ionizing radiation during childhood is a well-established risk factor for thyroid cancer. However, the genetic mechanisms of radiation-associated carcinogenesis remain not fully understood. Methods: In this study, we used targeted next-generation sequencing and RNA-Seq to study 65 papillary thyroid cancers (PTCs) from patients in the Ukrainian-American cohort with measurement-based iodine-131 (I-131) thyroid doses received as a result of the Chernobyl accident. We fitted linear regression models to evaluate differences in distribution of risk factors for PTC according to type of genetic alteration and logistic regression models to evaluate the I-131 dose response. All statistical tests were two-sided. Results: Driver mutations were identified in 96.9% of these thyroid cancers, including point mutations in 26.2% and gene fusions in 70.8% of cases. Novel driver fusions such as POR-BRAF, as well as STRN-ALK fusions that have not been implicated in radiation-associated cancer before, were found. The mean I-131 dose in cases with point mutations was 0.2 Gy (range = 0.013-1.05 Gy), statistically significantly lower than 1.4 Gy (range = 0.009-6.15 Gy) for cases with fusions (P < .001). No driver point mutations were found in tumors from individuals who received more than 1.1 Gy of radiation. Relative to tumors with point mutations, the proportion of tumors with gene fusions increased with radiation dose, reaching 87.8% among individuals exposed to 0.3 Gy or higher. With a limited study sample size, the estimated odds ratio at 1 Gy was 20.01 (95% confidence interval = 2.57 to 653.02, P < .001). In addition, after controlling for I-131 dose, we found higher odds ratios for gene fusion-positive PTCs associated with several specific demographic and geographic features. Conclusions: Our data provide support for a link between I-131 thyroid dose and generation of carcinogenic gene fusions, the predominant mechanism of thyroid cancer associated with radiation exposure from the Chernobyl accident.
Background: Exposure to ionizing radiation during childhood is a well-established risk factor for thyroid cancer. However, the genetic mechanisms of radiation-associated carcinogenesis remain not fully understood. Methods: In this study, we used targeted next-generation sequencing and RNA-Seq to study 65 papillary thyroid cancers (PTCs) from patients in the Ukrainian-American cohort with measurement-based iodine-131 (I-131) thyroid doses received as a result of the Chernobyl accident. We fitted linear regression models to evaluate differences in distribution of risk factors for PTC according to type of genetic alteration and logistic regression models to evaluate the I-131 dose response. All statistical tests were two-sided. Results: Driver mutations were identified in 96.9% of these thyroid cancers, including point mutations in 26.2% and gene fusions in 70.8% of cases. Novel driver fusions such as POR-BRAF, as well as STRN-ALK fusions that have not been implicated in radiation-associated cancer before, were found. The mean I-131 dose in cases with point mutations was 0.2 Gy (range = 0.013-1.05 Gy), statistically significantly lower than 1.4 Gy (range = 0.009-6.15 Gy) for cases with fusions (P < .001). No driver point mutations were found in tumors from individuals who received more than 1.1 Gy of radiation. Relative to tumors with point mutations, the proportion of tumors with gene fusions increased with radiation dose, reaching 87.8% among individuals exposed to 0.3 Gy or higher. With a limited study sample size, the estimated odds ratio at 1 Gy was 20.01 (95% confidence interval = 2.57 to 653.02, P < .001). In addition, after controlling for I-131 dose, we found higher odds ratios for gene fusion-positive PTCs associated with several specific demographic and geographic features. Conclusions: Our data provide support for a link between I-131 thyroid dose and generation of carcinogenic gene fusions, the predominant mechanism of thyroid cancer associated with radiation exposure from the Chernobyl accident.
Authors: Lindsey M Kelly; Guillermo Barila; Pengyuan Liu; Viktoria N Evdokimova; Sumita Trivedi; Federica Panebianco; Manoj Gandhi; Sally E Carty; Steven P Hodak; Jianhua Luo; Sanja Dacic; Yan P Yu; Marina N Nikiforova; Robert L Ferris; Daniel L Altschuler; Yuri E Nikiforov Journal: Proc Natl Acad Sci U S A Date: 2014-02-03 Impact factor: 11.205
Authors: F Pacini; T Vorontsova; E P Demidchik; E Molinaro; L Agate; C Romei; E Shavrova; E D Cherstvoy; Y Ivashkevitch; E Kuchinskaya; M Schlumberger; G Ronga; M Filesi; A Pinchera Journal: J Clin Endocrinol Metab Date: 1997-11 Impact factor: 5.958
Authors: Lene H S Veiga; Erik Holmberg; Harald Anderson; Linda Pottern; Siegal Sadetzki; M Jacob Adams; Ritsu Sakata; Arthur B Schneider; Peter Inskip; Parveen Bhatti; Robert Johansson; Gila Neta; Roy Shore; Florent de Vathaire; Lena Damber; Ruth Kleinerman; Michael M Hawkins; Margaret Tucker; Marie Lundell; Jay H Lubin Journal: Radiat Res Date: 2016-04-29 Impact factor: 2.841
Authors: Yuri E Nikiforov; Sally E Carty; Simon I Chiosea; Christopher Coyne; Umamaheswar Duvvuri; Robert L Ferris; William E Gooding; Steven P Hodak; Shane O LeBeau; N Paul Ohori; Raja R Seethala; Mitchell E Tublin; Linwah Yip; Marina N Nikiforova Journal: Cancer Date: 2014-09-10 Impact factor: 6.860
Authors: L B Zablotska; E Ron; A V Rozhko; M Hatch; O N Polyanskaya; A V Brenner; J Lubin; G N Romanov; R J McConnell; P O'Kane; V V Evseenko; V V Drozdovitch; N Luckyanov; V F Minenko; A Bouville; V B Masyakin Journal: Br J Cancer Date: 2010-11-23 Impact factor: 7.640
Authors: Alyaksandr V Nikitski; Susan L Rominski; Mamta Wankhede; Lindsey M Kelly; Federica Panebianco; Guillermo Barila; Daniel L Altschuler; Yuri E Nikiforov Journal: Am J Pathol Date: 2018-08-18 Impact factor: 4.307
Authors: Carlos S Duque; Alejandro Vélez; Jorge Cuartas; Fabian Jaimes; Juan Pablo Dueñas; Miguel Agudelo; Marina N Nikiforova; Yuri E Nikiforov; Vincenzo Condello Journal: Endocrine Date: 2022-01-30 Impact factor: 3.925
Authors: Lindsay M Morton; Danielle M Karyadi; Chip Stewart; Tetiana I Bogdanova; Eric T Dawson; Mia K Steinberg; Jieqiong Dai; Stephen W Hartley; Sara J Schonfeld; Joshua N Sampson; Yosef E Maruvka; Vidushi Kapoor; Dale A Ramsden; Juan Carvajal-Garcia; Charles M Perou; Joel S Parker; Marko Krznaric; Meredith Yeager; Joseph F Boland; Amy Hutchinson; Belynda D Hicks; Casey L Dagnall; Julie M Gastier-Foster; Jay Bowen; Olivia Lee; Mitchell J Machiela; Elizabeth K Cahoon; Alina V Brenner; Kiyohiko Mabuchi; Vladimir Drozdovitch; Sergii Masiuk; Mykola Chepurny; Liudmyla Yu Zurnadzhy; Maureen Hatch; Amy Berrington de Gonzalez; Gerry A Thomas; Mykola D Tronko; Gad Getz; Stephen J Chanock Journal: Science Date: 2021-04-22 Impact factor: 63.714
Authors: Hannah Kohler; Soeren Latteyer; Georg Sebastian Hönes; Sarah Theurer; Xiao-Hui Liao; Sandra Christoph; Denise Zwanziger; Johannes H Schulte; Jukka Kero; Hendrik Undeutsch; Samuel Refetoff; Kurt W Schmid; Dagmar Führer; Lars C Moeller Journal: Thyroid Date: 2019-10-08 Impact factor: 6.568